To ensure sustainability, we expanded our operations by establishing our own in-house research and development arm. What started as a single research project in 2013 has led to the development of a range of new product derivatives from our core technologies, allowing us to serve a wider audience and address previously unmet medical needs. Our research efforts continue to this day and we have several more projects in the pipeline. We welcome new partnerships and funding opportunities to support our growth.

We are actively involved, from detecting illness and determining disease to providing treatments and monitoring progress of research.